Wednesday, September 16, 2026

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Must Read



In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.



Source link

- Advertisement -spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -spot_img
Latest News

The Top NYFW Street Style Trends of the Season

Fact: New Yorkers have great style 365 days a year. When fashion week rolls into town, however, the...
- Advertisement -spot_img

More Articles Like This

- Advertisement -spot_img